menu search

Takeda provides update on tak-994 clinical program

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda pharmaceutical Company Limited (TSE:4502/NYSE:...

October 5, 2021, 7:33 pm

Takeda provides update on tak-994 clinical program

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda pharmaceutical Company Limited (TSE:4502/NYSE:...

October 5, 2021, 7:33 pm

Takeda provides update on tak-994 clinical program

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda pharmaceutical Company Limited (TSE:4502/NYSE:...

October 5, 2021, 7:33 pm

Takeda provides update on tak-994 clinical program

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda pharmaceutical Company Limited (TSE:4502/NYSE:...

October 5, 2021, 7:33 pm

Takeda provides update on tak-994 clinical program

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda pharmaceutical Company Limited (TSE:4502/NYSE:...

October 5, 2021, 7:33 pm

5 high-quality stocks outperforming the s&p 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to ...

October 5, 2021, 4:44 pm

5 high-quality stocks outperforming the s&p 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to ...

October 5, 2021, 4:44 pm

5 high-quality stocks outperforming the s&p 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to ...

October 5, 2021, 4:44 pm

5 high-quality stocks outperforming the s&p 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to ...

October 5, 2021, 4:44 pm

5 high-quality stocks outperforming the s&p 500

In light of increasing market volatility, five stocks with high business quality and have outperformed the Standard & Poor's 500 index in the year to ...

October 5, 2021, 4:44 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Neurobo pharmaceuticals closes $14 million registered direct offering

BOSTON, Oct. 5, 2021 /PRNewswire/ -- NeuroBo pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage b...

October 5, 2021, 1:13 pm

Is xenon pharmaceuticals a good stock to buy now?

Despite the big run-up yesterday, there could be enough fuel to push this biotech stock even higher....

October 5, 2021, 5:42 am

Is xenon pharmaceuticals a good stock to buy now?

Despite the big run-up yesterday, there could be enough fuel to push this biotech stock even higher....

October 5, 2021, 5:42 am

Is xenon pharmaceuticals a good stock to buy now?

Despite the big run-up yesterday, there could be enough fuel to push this biotech stock even higher....

October 5, 2021, 5:42 am


Search within

Pages Search Results: